> top > docs > PMC:7386875 > spans > 50818-52131 > annotations

PMC:7386875 / 50818-52131 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T507 165-173 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T508 380-389 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T509 595-603 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T510 829-839 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T511 1086-1094 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T379 142-150 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T380 478-486 Disease denotes thrombus http://purl.obolibrary.org/obo/MONDO_0000831
T381 517-527 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T382 1153-1174 Disease denotes hereditary angioedema http://purl.obolibrary.org/obo/MONDO_0019623
T383 1164-1174 Disease denotes angioedema http://purl.obolibrary.org/obo/MONDO_0010481

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T532 0-10 http://purl.obolibrary.org/obo/CLO_0001658 denotes Activation
T533 55-65 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T534 241-251 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T535 334-344 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T536 500-506 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T537 607-613 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T538 671-672 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T539 763-764 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T540 817-827 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T541 1067-1068 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T542 1095-1098 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T543 1200-1201 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T84764 88-97 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T40796 255-265 Chemical denotes bradykinin http://purl.obolibrary.org/obo/CHEBI_3165
T14978 859-861 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T87766 914-924 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T87872 1252-1275 Chemical denotes anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T434 1270-1275 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T73 1164-1174 Phenotype denotes angioedema http://purl.obolibrary.org/obo/HP_0100665

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T155 323-344 http://purl.obolibrary.org/obo/GO_0006956 denotes complement activation
T156 487-496 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T157 545-555 http://purl.obolibrary.org/obo/GO_0007599 denotes hemostasis
T158 633-654 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T159 806-827 http://purl.obolibrary.org/obo/GO_0006956 denotes complement activation
T160 829-853 http://purl.obolibrary.org/obo/GO_0043312 denotes neutrophil degranulation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T174 0-1313 Sentence denotes Activation of the contact pathway is initiated by FXII activation by negatively charged molecules such as NETs, which are increased in severe COVID-19 patients, and platelet-derived PolyP.100 This leads to the generation of thrombin and the activation of bradykinin, of which the latter in particular results in downstream complement activation and the production of inflammatory cytokines.149 Importantly, therapeutic inhibition of FXIIa demonstrates protection from occlusive thrombus formation in animal models of thrombosis without impeding hemostasis.150 Treatment with an inhibitory FXIIa antibody in animal models of systemic inflammatory response syndrome, using a lethal E coli challenge, have shown that FXIIa inhibition improves survival and decreases a number of inflammatory markers including complement activation, neutrophil degranulation, and IL-6.151–153 Importantly, the potential safety of FXII inhibitors is highlighted by the fact that FXII-deficient individuals display no bleeding phenotype, and there is no known effect on immune function.154 A FXIIa inhibitory antibody has recently entered clinical trials for the treatment of hereditary angioedema and therefore represents a promising novel combination of antithrombotic and anti-inflammatory drugs (URL: https://www.clinicaltrials.gov.

2_test

Id Subject Object Predicate Lexical cue
32586214-29483100-21597821 188-191 29483100 denotes 100
32586214-31507606-21597822 390-393 31507606 denotes 149
32586214-7678610-21597823 864-867 7678610 denotes 151
32586214-32542210-21597823 864-867 32542210 denotes 151
32586214-8630396-21597823 864-867 8630396 denotes 151
32586214-22993391-21597824 1063-1066 22993391 denotes 154

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1692 224-232 Gene denotes thrombin Gene:2147
1693 255-265 Gene denotes bradykinin Gene:3827
1694 859-863 Gene denotes IL-6 Gene:3569
1695 151-159 Species denotes patients Tax:9606
1697 142-150 Disease denotes COVID-19 MESH:C000657245
1698 468-486 Disease denotes occlusive thrombus MESH:D013927
1699 517-527 Disease denotes thrombosis MESH:D013927
1700 995-1003 Disease denotes bleeding MESH:D006470
1701 1153-1174 Disease denotes hereditary angioedema MESH:D054179